Sheeba K Thomas

15PUBLICATIONS
66CO-AUTHORS
Haematological tumoursMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicineApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 31, 2026
Phase 1/2 trial of Evomela for autologous transplant in myeloma: schedule optimization and matched comparison with MEL200.

|Jul 24, 2026
Prognostic impact of monosomy 13 and deletion of 13q in multiple myeloma patients undergoing upfront autologous transplantation.

|Jul 22, 2026
FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial.

|Jul 07, 2026
Single-cell analysis of the tumor microenvironment landscape across the disease spectrum of multiple myeloma.

|Jul 06, 2026
Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) induction prior to autologous haematopoietic stem cell transplant/transplantation in newly diagnosed multiple myeloma.

|Apr 15, 2026
Acalabrutinib in Waldenström macroglobulinemia yields durable responses with 5 years of follow-up.

Pageof 3

Frequent Collaborators

8 joint publications

Robert Z Orlowski

8 joint publications

Krina K Patel

7 joint publications

Oren Pasvolsky

6 joint publications

Yago Nieto